Position in URGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,917,172
-$839,677 QoQ
Shares Held
79,271
-50.6% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#52
of 190 holders
Holding Since
Sep 2023
3 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $124,057,032 across 35 Biotechnology names. URGN ranks #19 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
49,357 | $9,243,578 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
117,987 | $6,702,841 | |
| 3 | TWST |
Twist Bioscience Corp
|
62,564 | $6,436,584 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
26,152 | $6,401,225 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
19,498 | $6,163,122 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
16,227 | $6,031,089 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
24,544 | $5,914,367 | |
| 8 | CYTK |
Cytokinetics Inc
|
68,185 | $5,808,680 |
All Filings in URGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,917,172 | 79,271 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $3,756,849 | 160,412 | Shares | Sole | 2026-02-12 | |
| 2023-09-30 | $2,389,027 | 170,523 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||